NCT02489903 2025-03-17RRx-001 in Lung Cancer, Ovarian Cancer and Neuroendocrine Tumors Prior to Re-administration of Platinum Based Doublet Regimens (QUADRUPLE THREAT)EpicentRx, Inc.Phase 2 Completed139 enrolled 14 charts
NCT00191750 2007-01-26A Study of Pemetrexed in Small Cell Lung Cancer, Which Has ReturnedEli Lilly and CompanyPhase 2 Completed80 enrolled